drugset / Trial / NCT00672763

Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease

NCT00672763 ↗

Phase 4 Withdrawn Imperial College London
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether the addition of vitamin D to standard corticosteroids improves onset of remission in active Crohn's Disease, a form of Inflammatory Bowel Disease (IBD).

Timeline

Start
2008-05
Primary completion
2010-05
Completion
2010-05

Outcome

Outcome not reported

Stopped (Enrollment): “Unable to recruit adequate trial participants”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colecalciferol D3 Unknown 100000 iu Oral

Indications